BRUKER CORPORATION Other Nonrecurring (Income) Expense
BRUKER CORPORATION (BRKR) reported Other Nonrecurring (Income) Expense of $13.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherNonrecurringIncomeExpense · last filed 2026-08-05
- BRUKER CORPORATION other nonrecurring (income) expense for the quarter ending 2026-06-30 was $13.20M, a 8.33% decline year-over-year.
- BRUKER CORPORATION other nonrecurring (income) expense for the quarter ending 2026-03-31 was $26.20M, a 29.00% decline year-over-year.
- BRUKER CORPORATION other nonrecurring (income) expense for the quarter ending 2025-12-31 was $26.10M, a 62.45% decline year-over-year.
- BRUKER CORPORATION other nonrecurring (income) expense for the quarter ending 2025-09-30 was -$6.10M, a 126.87% decline year-over-year.
- BRUKER CORPORATION other nonrecurring (income) expense for fiscal 2025 was $71.30M, a 43.46% decline from fiscal 2024.
- BRUKER CORPORATION other nonrecurring (income) expense for fiscal 2024 was $126.10M, a 141.57% increase from fiscal 2023.
- BRUKER CORPORATION other nonrecurring (income) expense for fiscal 2023 was $52.20M, a 75.76% increase from fiscal 2022.
- BRUKER CORPORATION other nonrecurring (income) expense for fiscal 2022 was $29.70M, a 107.69% increase from fiscal 2021.
| Period end | Other Nonrecurring (Income) Expense 3 month | Other Nonrecurring (Income) Expense 6 month | Other Nonrecurring (Income) Expense 9 month | Other Nonrecurring (Income) Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.20M 10-Q · filed 2026-08-05 | $39.40M 10-Q · filed 2026-08-05 | $65.50M derived: sum of 3 quarters · filed 2026-08-05 | $59.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $26.20M 10-Q · filed 2026-05-07 | $52.30M derived: sum of 2 quarters · filed 2026-05-07 | $46.20M derived: sum of 3 quarters · filed 2026-05-07 | $60.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $26.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $20.00M derived: sum of 2 quarters · filed 2026-02-27 | $34.40M derived: sum of 3 quarters · filed 2026-08-05 | $71.30M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$6.10M 10-Q · filed 2025-11-05 | $8.30M derived: sum of 2 quarters · filed 2026-08-05 | $45.20M 10-Q · filed 2025-11-05 | $114.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $14.40M 10-Q · filed 2026-08-05 | $51.30M 10-Q · filed 2026-08-05 | $120.80M derived: sum of 3 quarters · filed 2026-08-05 | $143.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $36.90M 10-Q · filed 2026-05-07 | $106.40M derived: sum of 2 quarters · filed 2026-05-07 | $129.10M derived: sum of 3 quarters · filed 2026-05-07 | $152.10M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $69.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $92.20M derived: sum of 2 quarters · filed 2026-02-27 | $115.20M derived: sum of 3 quarters · filed 2026-02-27 | $126.10M 10-K · filed 2026-02-27 |
| 2024-09-30 | $22.70M 10-Q · filed 2025-11-05 | $45.70M derived: sum of 2 quarters · filed 2025-11-05 | $56.60M 10-Q · filed 2025-11-05 | $88.70M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $23.00M 10-Q · filed 2025-08-06 | $33.90M 10-Q · filed 2025-08-06 | $66.00M derived: sum of 3 quarters · filed 2026-02-27 | $75.40M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $10.90M 10-Q · filed 2025-05-07 | $43.00M derived: sum of 2 quarters · filed 2026-02-27 | $52.40M derived: sum of 3 quarters · filed 2026-02-27 | $57.80M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $32.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $41.50M derived: sum of 2 quarters · filed 2026-02-27 | $46.90M derived: sum of 3 quarters · filed 2026-02-27 | $52.20M 10-K · filed 2026-02-27 |
| 2023-09-30 | $9.40M 10-Q · filed 2024-11-07 | $14.80M derived: sum of 2 quarters · filed 2024-11-07 | $20.10M 10-Q · filed 2024-11-07 | $26.80M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $5.40M 10-Q · filed 2024-08-09 | $10.70M 10-Q · filed 2024-08-09 | $17.40M derived: sum of 3 quarters · filed 2025-03-03 | $20.40M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $5.30M 10-Q · filed 2024-05-10 | $12.00M derived: sum of 2 quarters · filed 2025-03-03 | $15.00M derived: sum of 3 quarters · filed 2025-03-03 | $27.50M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $9.70M derived: sum of 2 quarters · filed 2025-03-03 | $22.20M derived: sum of 3 quarters · filed 2025-03-03 | $29.70M 10-K · filed 2025-03-03 |
| 2022-09-30 | $3.00M 10-Q · filed 2023-11-09 | $15.50M derived: sum of 2 quarters · filed 2023-11-09 | $23.00M 10-Q · filed 2023-11-09 | $27.80M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $12.50M 10-Q · filed 2023-08-09 | $20.00M 10-Q · filed 2023-08-09 | $24.80M derived: sum of 3 quarters · filed 2024-02-29 | $26.90M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $7.50M 10-Q · filed 2023-05-10 | $12.30M derived: sum of 2 quarters · filed 2024-02-29 | $14.40M derived: sum of 3 quarters · filed 2024-02-29 | $18.80M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $6.90M derived: sum of 2 quarters · filed 2024-02-29 | $11.30M derived: sum of 3 quarters · filed 2024-02-29 | $14.30M 10-K · filed 2024-02-29 |
| 2021-09-30 | $2.10M 10-Q · filed 2022-11-04 | $6.50M derived: sum of 2 quarters · filed 2022-11-04 | $9.50M 10-Q · filed 2022-11-04 | $22.20M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $4.40M 10-Q · filed 2022-08-05 | $7.40M 10-Q · filed 2022-08-05 | $20.10M derived: sum of 3 quarters · filed 2023-03-01 | $24.30M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $3.00M 10-Q · filed 2022-05-06 | $15.70M derived: sum of 2 quarters · filed 2023-03-01 | $19.90M derived: sum of 3 quarters · filed 2023-03-01 | $21.70M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $16.90M derived: sum of 2 quarters · filed 2023-03-01 | $18.70M derived: sum of 3 quarters · filed 2023-03-01 | $24.90M 10-K · filed 2023-03-01 |
| 2020-09-30 | $4.20M 10-Q · filed 2021-11-05 | $6.00M derived: sum of 2 quarters · filed 2021-11-05 | $12.20M 10-Q · filed 2021-11-05 | $13.80M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $1.80M 10-Q · filed 2021-08-05 | $8.00M 10-Q · filed 2021-08-05 | $9.60M derived: sum of 3 quarters · filed 2022-02-28 | $4.30M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $6.20M 10-Q · filed 2021-05-10 | $7.80M derived: sum of 2 quarters · filed 2022-02-28 | $2.50M derived: sum of 3 quarters · filed 2022-02-28 | $6.40M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$3.70M derived: sum of 2 quarters · filed 2022-02-28 | $200.00K derived: sum of 3 quarters · filed 2022-02-28 | $6.50M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$5.30M 10-Q · filed 2020-11-06 | -$1.40M derived: sum of 2 quarters · filed 2020-11-06 | $4.90M 10-Q · filed 2020-11-06 | $9.20M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $3.90M 10-Q · filed 2020-08-07 | $10.20M 10-Q · filed 2020-08-07 | $14.50M derived: sum of 3 quarters · filed 2021-03-01 | $19.70M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $6.30M 10-Q · filed 2020-05-11 | $10.60M derived: sum of 2 quarters · filed 2021-03-01 | $15.80M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $9.50M derived: sum of 2 quarters · filed 2021-03-01 | $19.50M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $5.20M 10-Q · filed 2019-11-04 | $15.20M 10-Q · filed 2019-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |